2 years ago

Entia Secures $12 Million to Launch Virtual Oncology Solution

  • Entia, a UK-based medical technology company, raised $12 million in Series A funding led by BGF, with participation from existing seed investors including Parkwalk and Sussex Place Ventures

  • The company intends to use the funds to launch Entia Liberty, a virtual oncology solution that allows patients to perform their own blood tests at home

  • Entia has partnerships with healthcare institutions such as The Christie NHS Foundation Trust and Pfizer UK.

      • ProblemHealthcare

      "managing haematological toxicity of cancer treatment"

      Solution

      "a virtual oncology solution that allows patients to perform their own blood tests at home, monitored by remote healthcare teams"

      Covered on